Renoprotective effects of tubular glucagon receptor activation mediated by V-ATPase
{{output}}
Recent clinical trials have shown that dual GLP-1R/GCGR agonists, including mazdutide and cotadutide, provide kidney benefits in patients with type 2 diabetes and CKD, suggesting a potential contribution of GCGR activation to these renal effects. However, whet... ...
